Literature DB >> 22612820

Abnormal dendrite and spine morphology in primary visual cortex in the CGG knock-in mouse model of the fragile X premutation.

Robert F Berman1, Karl D Murray, Gloria Arque, Michael R Hunsaker, H Jürgen Wenzel.   

Abstract

The fragile X mental retardation 1 gene (Fmr1) is polymorphic for CGG trinucleotide repeat number in the 5'-untranslated region, with repeat lengths <45 associated with typical development and repeat lengths >200 resulting in hypermethylation and transcriptional silencing of the gene and mental retardation in the fragile X Syndrome (FXS). Individuals with CGG repeat expansions between 55 and 200 are carriers of the fragile X premutation (PM). PM carriers show a phenotype that can include anxiety, depression, social phobia, and memory deficits. They are also at risk for developing fragile X-associated tremor/ataxia syndrome (FXTAS), a late onset neurodegenerative disorder characterized by tremor, ataxia, cognitive impairment, and neuropathologic features including intranuclear inclusions in neurons and astrocytes, loss of Purkinje cells, and white matter disease. However, very little is known about dendritic morphology in PM or in FXTAS. Therefore, we carried out a Golgi study of dendritic complexity and dendritic spine morphology in layer II/III pyramidal neurons in primary visual cortex in a knock-in (KI) mouse model of the PM. These CGG KI mice carry an expanded CGG trinucleotide repeat on Fmr1, and model many features of the PM and FXTAS. Compared to wild-type (WT) mice, CGG KI mice showed fewer dendritic branches proximal to the soma, reduced total dendritic length, and a higher frequency of longer dendritic spines. The distribution of morphologic spine types (e.g., stubby, mushroom, filopodial) did not differ between WT and KI mice. These findings demonstrate that synaptic circuitry is abnormal in visual cortex of mice used to model the PM, and suggest that such changes may underlie neurologic features found in individuals carrying the PM as well as in individuals with FXTAS. Wiley Periodicals, Inc.
© 2012 International League Against Epilepsy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22612820      PMCID: PMC4316681          DOI: 10.1111/j.1528-1167.2012.03486.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  58 in total

1.  Intranuclear inclusions in neural cells with premutation alleles in fragile X associated tremor/ataxia syndrome.

Authors:  F Tassone; R J Hagerman; D Garcia-Arocena; E W Khandjian; C M Greco; P J Hagerman
Journal:  J Med Genet       Date:  2004-04       Impact factor: 6.318

Review 2.  Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function.

Authors:  Gary J Bassell; Stephen T Warren
Journal:  Neuron       Date:  2008-10-23       Impact factor: 17.173

3.  Temporal ordering deficits in female CGG KI mice heterozygous for the fragile X premutation.

Authors:  Michael R Hunsaker; Naomi J Goodrich-Hunsaker; Rob Willemsen; Robert F Berman
Journal:  Behav Brain Res       Date:  2010-05-15       Impact factor: 3.332

4.  The fragile X prevalence paradox.

Authors:  Paul J Hagerman
Journal:  J Med Genet       Date:  2008-04-15       Impact factor: 6.318

5.  Analysis of neocortex in three males with the fragile X syndrome.

Authors:  V J Hinton; W T Brown; K Wisniewski; R D Rudelli
Journal:  Am J Med Genet       Date:  1991-12-01

6.  Calibration of an autocorrelation-based method for determining amplitude histogram reliability and quantal size.

Authors:  K J Stratford; J J Jack; A U Larkman
Journal:  J Physiol       Date:  1997-12-01       Impact factor: 5.182

7.  Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation.

Authors:  David Hessl; Flora Tassone; Danuta Z Loesch; Elizabeth Berry-Kravis; Maureen A Leehey; Louise W Gane; Ingrid Barbato; Cathlin Rice; Emma Gould; Deborah A Hall; James Grigsby; Jacob A Wegelin; Susan Harris; Foster Lewin; Dahlia Weinberg; Paul J Hagerman; Randi J Hagerman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2005-11-05       Impact factor: 3.568

8.  Sam68 sequestration and partial loss of function are associated with splicing alterations in FXTAS patients.

Authors:  Chantal Sellier; Frédérique Rau; Yilei Liu; Flora Tassone; Renate K Hukema; Renata Gattoni; Anne Schneider; Stéphane Richard; Rob Willemsen; David J Elliott; Paul J Hagerman; Nicolas Charlet-Berguerand
Journal:  EMBO J       Date:  2010-02-25       Impact factor: 11.598

9.  The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome.

Authors:  Rob Willemsen; Marianne Hoogeveen-Westerveld; Surya Reis; Joan Holstege; Lies-Anne W F M Severijnen; Ingeborg M Nieuwenhuizen; Mariette Schrier; Leontine van Unen; Flora Tassone; Andre T Hoogeveen; Paul J Hagerman; Edwin J Mientjes; Ben A Oostra
Journal:  Hum Mol Genet       Date:  2003-05-01       Impact factor: 6.150

10.  Adult Female Fragile X Premutation Carriers Exhibit Age- and CGG Repeat Length-Related Impairments on an Attentionally Based Enumeration Task.

Authors:  Naomi J Goodrich-Hunsaker; Ling M Wong; Yingratana McLennan; Flora Tassone; Danielle Harvey; Susan M Rivera; Tony J Simon
Journal:  Front Hum Neurosci       Date:  2011-07-14       Impact factor: 3.169

View more
  27 in total

Review 1.  Dendrite and spine modifications in autism and related neurodevelopmental disorders in patients and animal models.

Authors:  Verónica Martínez-Cerdeño
Journal:  Dev Neurobiol       Date:  2016-08-30       Impact factor: 3.964

Review 2.  Fragile X-associated tremor/ataxia syndrome (FXTAS): pathology and mechanisms.

Authors:  Paul Hagerman
Journal:  Acta Neuropathol       Date:  2013-06-21       Impact factor: 17.088

Review 3.  What has been learned from mouse models of the Fragile X Premutation and Fragile X-associated tremor/ataxia syndrome?

Authors:  Molly M Foote; Milo Careaga; Robert F Berman
Journal:  Clin Neuropsychol       Date:  2016-06-29       Impact factor: 3.535

Review 4.  Lens Biology is a Dimension of Neurobiology.

Authors:  Peter Frederikse; Chinnaswamy Kasinathan
Journal:  Neurochem Res       Date:  2017-02-04       Impact factor: 3.996

5.  Calcium dysregulation and Cdk5-ATM pathway involved in a mouse model of fragile X-associated tremor/ataxia syndrome.

Authors:  Gaëlle Robin; José R López; Glenda M Espinal; Susan Hulsizer; Paul J Hagerman; Isaac N Pessah
Journal:  Hum Mol Genet       Date:  2017-07-15       Impact factor: 6.150

6.  The Autism Protein Ube3A/E6AP Remodels Neuronal Dendritic Arborization via Caspase-Dependent Microtubule Destabilization.

Authors:  Natasha Khatri; James P Gilbert; Yuda Huo; Roozhin Sharaflari; Michael Nee; Hui Qiao; Heng-Ye Man
Journal:  J Neurosci       Date:  2017-12-04       Impact factor: 6.167

7.  Reduced excitatory amino acid transporter 1 and metabotropic glutamate receptor 5 expression in the cerebellum of fragile X mental retardation gene 1 premutation carriers with fragile X-associated tremor/ataxia syndrome.

Authors:  Dalyir I Pretto; Madhur Kumar; Zhengyu Cao; Christopher L Cunningham; Blythe Durbin-Johnson; Lihong Qi; Robert Berman; Stephen C Noctor; Randi J Hagerman; Isaac N Pessah; Flora Tassone
Journal:  Neurobiol Aging       Date:  2013-11-16       Impact factor: 4.673

8.  CGG trinucleotide repeat length modulates neural plasticity and spatiotemporal processing in a mouse model of the fragile X premutation.

Authors:  Michael R Hunsaker; Kyoungmi Kim; Rob Willemsen; Robert F Berman
Journal:  Hippocampus       Date:  2012-06-18       Impact factor: 3.899

9.  CNS expression of murine fragile X protein (FMRP) as a function of CGG-repeat size.

Authors:  Anna Lisa Ludwig; Glenda M Espinal; Dalyir I Pretto; Amanda L Jamal; Gloria Arque; Flora Tassone; Robert F Berman; Paul J Hagerman
Journal:  Hum Mol Genet       Date:  2014-01-23       Impact factor: 6.150

10.  Early mitochondrial abnormalities in hippocampal neurons cultured from Fmr1 pre-mutation mouse model.

Authors:  Eitan S Kaplan; Zhengyu Cao; Susan Hulsizer; Flora Tassone; Robert F Berman; Paul J Hagerman; Isaac N Pessah
Journal:  J Neurochem       Date:  2012-09-28       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.